Drug class in one race
Amylin/calcitonin receptor (dual) drugs for Obesity
3 tracked Amylin/calcitonin receptor (dual) drugs in the Obesity race. The class explanation lives on the Amylin/calcitonin receptor (dual) page; the full indication pipeline across every mechanism is on the Obesity page.
2 Phase 31 Phase 1
Head-to-head evidence: BGM1812 vs cagrilintide · BGM1812 vs petrelintide · cagrilintide vs petrelintide